MALIGNANT MESOTHELIOMA
Clinical trials for MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immune cells from lung fluid could fight advanced cancer
Disease control Recruiting nowThis early-phase study tests a new treatment for people whose cancer has spread to the lining around the lungs (pleura) or who have pleural mesothelioma. Doctors will collect immune cells from the patient's own pleural fluid, grow them in a lab, and inject them back into the ches…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: David Bartlett, MD • Aim: Disease control
Last updated May 26, 2026 11:55 UTC
-
New hope for mesothelioma patients: targeted therapy shows promise
Disease control Recruiting nowThis study tests a drug called brentuximab vedotin in people with a rare cancer called CD30+ malignant mesothelioma that cannot be removed by surgery. The drug works like a smart bomb, targeting a specific protein on cancer cells to stop them from growing. About 55 participants w…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:09 UTC
-
Scientists use patients' own lung fluid cells to fight advanced cancer
Disease control Recruiting nowThis early-phase study tests a new treatment for people whose cancer has spread to the lining of the lungs (pleura) or who have mesothelioma. Doctors collect fluid from around the lungs, grow the patient's own immune cells in a lab, and then put them back into the chest along wit…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New drug trial hopes to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests an experimental drug called ISM6331 in people with advanced mesothelioma or other solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 10…
Matched conditions: MALIGNANT MESOTHELIOMA
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 20, 2026 11:55 UTC